{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:35:43Z","timestamp":1790181343020,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.nmd.2022.09.001","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T18:17:51Z","timestamp":1662401871000},"page":"785-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature"],"prefix":"10.1016","volume":"32","author":[{"given":"Sithara","family":"Ramdas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan Malcolm","family":"Hum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Bland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Farrugia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Storrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Standing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Lilleker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7159-3427","authenticated-orcid":false,"given":"Heinz","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nmd.2022.09.001_bib0001","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: a systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.nmd.2022.09.001_bib0002","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis - a comprehensive review","volume":"52","author":"Avidan","year":"2014","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.nmd.2022.09.001_bib0003","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.nmd.2022.09.001_bib0004","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/BOR.0b013e3282f0ad25","article-title":"Viral infection can induce the production of autoantibodies","volume":"19","author":"Barzilai","year":"2007","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.nmd.2022.09.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.nmd.2022.09.001_bib0006","first-page":"1","article-title":"Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients","volume":"3","author":"Sansone","year":"2022","journal-title":"J Neurol"},{"issue":"15","key":"10.1016\/j.nmd.2022.09.001_bib0007","doi-asserted-by":"crossref","first-page":"P6.437","DOI":"10.1212\/WNL.90.15_supplement.P6.437","article-title":"Myasthenia gravis after vaccination in adults the United States: a report from the CDC\/FDA vaccine adverse event reporting system (1990\u20132017)","volume":"90","author":"Sanghani","year":"2018","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.nmd.2022.09.001_bib0008","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1080\/21645515.2021.1977580","article-title":"Laryngeal myasthenia gravis following influenza vaccination: a case report and literature review","volume":"17","author":"Wang","year":"2021","journal-title":"Hum Vaccines Immunother"},{"issue":"46","key":"10.1016\/j.nmd.2022.09.001_bib0009","doi-asserted-by":"crossref","first-page":"e8757","DOI":"10.1097\/MD.0000000000008757","article-title":"New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: a case report and literature review","volume":"96","author":"Takizawa","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.nmd.2022.09.001_bib0010","doi-asserted-by":"crossref","first-page":"A226","DOI":"10.1136\/annrheumdis-2001.569","article-title":"FRI0248 myasthenia gravis after hepatitis B vaccine. Report of one case","volume":"60","author":"Bahri","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"1-2","key":"10.1016\/j.nmd.2022.09.001_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2010.02.016","article-title":"Neuromuscular disorders associated with hepatitis B vaccination","volume":"292","author":"St\u00fcbgen","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2022.09.001_bib0012","article-title":"Myasthenia gravis following human papillomavirus vaccination: a case report","volume":"222","author":"Chung","year":"2018","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2022.09.001_bib0013","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/mus.26328","article-title":"New onset of seropositive generalized myasthenia gravis following intravesical bacille Calmette-Guerin treatment for bladder cancer: a case study","volume":"59","author":"Davalos","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.09.001_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/21501327211051933","article-title":"A case of COVID-19 vaccine associated new diagnosis myasthenia gravis","volume":"12","author":"Chavez","year":"2021","journal-title":"J Prim Care Community Health"},{"issue":"10","key":"10.1016\/j.nmd.2022.09.001_bib0015","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.3346\/jkms.2022.37.e50","article-title":"Early-onset myasthenia gravis following COVID-19 vaccination","volume":"37","author":"Lee","year":"2022","journal-title":"J Korean Med Sci"},{"issue":"5","key":"10.1016\/j.nmd.2022.09.001_bib0016","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.nmd.2022.09.001_bib0017","first-page":"1","article-title":"Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine","author":"Maher","year":"2022","journal-title":"Orbit"},{"issue":"8","key":"10.1016\/j.nmd.2022.09.001_bib0018","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1007\/s00415-022-11140-9","article-title":"Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients","volume":"269","author":"Sansone","year":"2022","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2022.09.001_bib0019","first-page":"9","article-title":"Coincidental onset of ocular myasthenia gravis following chadox1 n-CoV-19 vaccine against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)","volume":"24","author":"Galassi","year":"2022","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.nmd.2022.09.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102592","article-title":"The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - a systematic review of the literature","volume":"117","author":"Novelli","year":"2021","journal-title":"J Autoimmun"},{"issue":"12","key":"10.1016\/j.nmd.2022.09.001_bib0021","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.3390\/cells10123592","article-title":"New onset of autoimmune diseases following COVID-19 diagnosis","volume":"10","author":"Gracia-Ramos","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.nmd.2022.09.001_bib0022","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2352-4642(21)00193-0","article-title":"Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study","volume":"5","author":"Ray","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"issue":"5","key":"10.1016\/j.nmd.2022.09.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12131","article-title":"Global incidence of neurological manifestations among patients hospitalized with COVID-19-a report for the GCS-NeuroCOVID consortium and the energy consortium","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.nmd.2022.09.001_bib0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JND-180313","article-title":"Serum acetylcholine receptor antibodies before the clinical onset of myasthenia gravis","volume":"5","author":"Strijbos","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2022.09.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106045","article-title":"COVID-19 and generalized myasthenia gravis exacerbation: a case report","volume":"196","author":"Singh","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"10.1016\/j.nmd.2022.09.001_bib0026","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.7326\/L20-0845","article-title":"Myasthenia gravis associated with SARS-CoV-2 infection","volume":"173","author":"Restivo","year":"2020","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.nmd.2022.09.001_bib0027","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","article-title":"COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)","volume":"19","author":"Muppidi","year":"2020","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2022.09.001_bib0028","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mus.26918","article-title":"COVID-19 in patients with myasthenia gravis","volume":"62","author":"Anand","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.09.001_bib0029","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","article-title":"Myasthenia gravis and COVID-19: clinical characteristics and outcomes","volume":"11","author":"Camelo-Filho","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2022.09.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106834","article-title":"Myasthenia gravis associated with novel Coronavirus 2019 infection: a report of three cases","volume":"208","author":"Karimi","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"10.1016\/j.nmd.2022.09.001_bib0031","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1111\/ene.14721","article-title":"Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection","volume":"28","author":"Assini","year":"2021","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.nmd.2022.09.001_bib0032","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1007\/s00415-020-10263-1","article-title":"New onset of ocular myasthenia gravis in a patient with SARS-COV-2: a novel case report and literature review","volume":"268","author":"Sriwastava","year":"2021","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2022.09.001_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-244146","article-title":"Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?","volume":"14","author":"Muralidhar Reddy","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.nmd.2022.09.001_bib0034","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s10072-021-05823-w","article-title":"Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review","volume":"43","author":"Rodrigues","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nmd.2022.09.001_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107970","article-title":"Autoimmune phenomena following SARS-CoV-2 vaccination","volume":"99","author":"Ishay","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"10.1016\/j.nmd.2022.09.001_bib0036","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1111\/trf.16672","article-title":"Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine","volume":"61","author":"Gadi","year":"2021","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.nmd.2022.09.001_bib0037","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ane.13550","article-title":"Neurological side effects of SARS-CoV-2 vaccinations","volume":"145","author":"Finsterer","year":"2022","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.nmd.2022.09.001_bib0038","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S2352-3026(21)00306-9","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"9","author":"Klok","year":"2022","journal-title":"Lancet Haematol"},{"issue":"10","key":"10.1016\/j.nmd.2022.09.001_bib0039","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/vaccines9101112","article-title":"Covid-19 vaccination in patients with myasthenia gravis: a single-center case series","volume":"9","author":"Ruan","year":"2021","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.nmd.2022.09.001_bib0040","first-page":"e15581","article-title":"A case of COVID-19 vaccine causing a myasthenia gravis crisis","volume":"13","author":"Tagliaferri","year":"2021","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.nmd.2022.09.001_bib0041","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/ene.15348","article-title":"Safety and tolerability of SARS-CoV-2 vaccination in patients with myasthenia gravis: a multicenter experience","volume":"29","author":"Farina","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2022.09.001_bib0042","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.nmd.2022.09.001_bib0043","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.vaccine.2019.01.007","article-title":"A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis","volume":"37","author":"Strijbos","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.nmd.2022.09.001_bib0044","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ebiom.2018.01.007","article-title":"Acetylcholine receptor antibody titers and clinical course after influenza vaccination in patients with myasthenia gravis: a double-blind randomized controlled trial (ProPATIent-Trial)","volume":"28","author":"Tackenberg","year":"2018","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.nmd.2022.09.001_bib0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.25267","article-title":"Molecular and clinical relationship between live- attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis","volume":"84","author":"He","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2022.09.001_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.834212","article-title":"The epidemiology and phenotypes of ocular manifestations in childhood and juvenile myasthenia gravis: a review","volume":"13","author":"Heckmann","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2022.09.001_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120225","article-title":"Flare of myasthenia gravis induced by COVID-19 vaccines","volume":"436","author":"Ishizuchi","year":"2022","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2022.09.001_bib0048","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.vaccine.2010.10.044","article-title":"Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination","volume":"29","author":"Koenig","year":"2011","journal-title":"Vaccine"},{"issue":"9396","key":"10.1016\/j.nmd.2022.09.001_bib0049","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.nmd.2022.09.001_bib0050","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/vaccines8030554","article-title":"Inflammasome-mediated immunogenicity of clinical and experimental vaccine adjuvants","volume":"8","author":"Reinke","year":"2020","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.nmd.2022.09.001_bib0051","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.nmd.2022.09.001_bib0052","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2019.04.001","article-title":"False-positive acetylcholine receptor antibody results in patients without myasthenia gravis","volume":"332","author":"Maddison","year":"2019","journal-title":"J Neuroimmunol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622006502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622006502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:12:25Z","timestamp":1760775145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622006502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0960896622006502"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.09.001","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}